NewslettersImmune Regulation News Additive Efficacy of a Bispecific Anti–TNF/IL-6 Nanobody Compound in Translational Models of Rheumatoid Arthritis By Laurisa Dohm - February 3, 2023 0 Combining anti-TNF and anti–IL-6 antibodies in collagen-induced arthritis mouse models resulted in sustained long-term remission, improved histology, and effects on bone remodeling pathways. [Science Translational Medicine] Full Article